- Home
- TOMZ vs ABP Comparison
TOMZ vs ABP Comparison
Compare TOMZ & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOMZ | ABP |
|---|---|---|
| Founded | 1979 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 15.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TOMZ | ABP |
|---|---|---|
| Price | $0.75 | $4.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | 13.8K | ★ 25.3K |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,688,341.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $68.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 50.00 |
| 52 Week Low | $0.63 | $4.55 |
| 52 Week High | $1.50 | $153.90 |
Technical Indicators
Market Signals| Indicator | TOMZ | ABP |
|---|---|---|
| Relative Strength Index (RSI) | 37.36 | 41.17 |
| Support Level | $0.73 | $4.59 |
| Resistance Level | $0.80 | $6.38 |
| Average True Range (ATR) | 0.02 | 0.57 |
| MACD | -0.00 | -0.33 |
| Stochastic Oscillator | 12.95 | 9.67 |
Price Performance
Historical ComparisonAbout TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About ABP Abpro Holdings Inc
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.